Zura Bio Limited, a multi-asset clinical-stage biotechnology company focused on developing medicines for immune and inflammatory disorders, appointed Michael Howell chief scientific officer and head of translational science. Howell brings more than two decades of experience leading discovery, translational research, and early clinical programs and will lead the scientific strategy and translational science efforts at Zura Bio. “I am thrilled to have Michael Howell join our team as our Chie...